What happens when artificial intelligence systems start to think for themselves, make themselves more powerful and escape human control in their quest to achieve superintelligence? That prospect has ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
Energy and gas juggernaut Shell is looking to offload its U.S. headquarters in Houston’s Energy Corridor for $325 million. Shell is still planning to maintain a smaller presence in the Woodcreek ...
HOUSTON — London-based Shell PLC (NYSE: SHEL) could sell its U.S. headquarters in Houston and its U.S. chemicals business. Green Street News reported that Shell listed its longtime Energy Corridor ...
Shell is selling its U.S. headquarters, asking about $325 million for the west Houston campus it has called home for more than four decades. While the energy giant plans to give up ownership of the ...
RENTON — Inside an unmarked warehouse in a nondescript industrial park sits the largest machine of its kind anywhere in North America, a whiz-bang contraption of zigzagging conveyor belts, robot arms, ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...